Compare TECX & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | VHI |
|---|---|---|
| Founded | 2019 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.3M | 448.3M |
| IPO Year | 2018 | 1994 |
| Metric | TECX | VHI |
|---|---|---|
| Price | $20.50 | $15.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 158.1K | 9.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ 40.70 | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | N/A | ★ $2,077,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.77 | $11.44 |
| 52 Week High | $39.53 | $19.19 |
| Indicator | TECX | VHI |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 50.13 |
| Support Level | $20.52 | $15.51 |
| Resistance Level | $22.95 | $17.52 |
| Average True Range (ATR) | 1.29 | 1.10 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 44.43 | 44.25 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.